/A
Phase 1
- Conditions
- _MedDRA version: 14.1 Level: LLT Classification code 10051975 Term: Salivary gland carcinoma System Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2012-004408-36-FR
- Lead Sponsor
- ICANCER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Not specified
- Target Recruitment
- 63
Inclusion Criteria
_
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 32
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 31
Exclusion Criteria
_
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: _;Secondary Objective: _;Primary end point(s): _;Timepoint(s) of evaluation of this end point: _
- Secondary Outcome Measures
Name Time Method Secondary end point(s): _;Timepoint(s) of evaluation of this end point: _